Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 247 for “"Immune Checkpoint Blockade"”.

  1. New approaches to treating cancer using immune-checkpoint blockade

    While immune-checkpoint blockade has truly revolutionised cancer treatment in many aspects, the benefits remain limited to certain tumour types. Furthermore, within those tumours that are likely to improve upon treatment, only a fraction of patients actually respond, which highlights the need for …

    oxford Repository record for New approaches to treating cancer using immune-checkpoint blockade (opens in a new tab)

  2. SILENCING XRN1 ENHANCED THE EFFECT OF IMMUNE CHECKPOINT BLOCKADE THERAPY

    Despite the remarkable achievement of immune checkpoint blockade (ICB) therapy, the response rate is relatively low and only a subset of patients can benefit from the treatment. We hypothesize that targeting RNA decay machinery may lead to accumulation of aberrant-RNA, triggering interferon (IFN) …

    nus Repository record for SILENCING XRN1 ENHANCED THE EFFECT OF IMMUNE CHECKPOINT BLOCKADE THERAPY (opens in a new tab) Download file for SILENCING XRN1 ENHANCED THE EFFECT OF IMMUNE CHECKPOINT BLOCKADE THERAPY (opens in a new tab)

  3. Pulsed photothermal therapy as a precondition for immune checkpoint blockade

    … can trigger certain physiological responses like immune stimulation and cytokine secretion. This immune response can be reinforced in combination with cancer immunotherapies such as immune checkpoint blockade. Although research has demonstrated that pulsed lasers generate more localized heating …

    ubc Repository record for Pulsed photothermal therapy as a precondition for immune checkpoint blockade (opens in a new tab) Download PDF for Pulsed photothermal therapy as a precondition for immune checkpoint blockade (opens in a new tab)

  4. Persistent Cancer Cells Alter Interferon Signaling After Immune Checkpoint Blockade

    Immune checkpoint blockade (ICB) therapies represent a groundbreaking paradigm in cancer treatment, reshaping clinical approaches. Despite their efficacy, relapse remains a common challenge with poorly understood acquired resistance mechanisms. In this study, leveraging multiple mouse models of ICB …

    penn Repository record for Persistent Cancer Cells Alter Interferon Signaling After Immune Checkpoint Blockade (opens in a new tab)

  5. A Fc Domain-Conjugated Adenosine 2A Receptor Ligand for Immune Checkpoint Blockade

    In light of the recent success of immune checkpoint blockade in cancer treatments, new inhibitory molecules and pathways have been increasingly considered as targets for cancer immunotherapy. The adenosine A2A receptor has long been regarded as an important checkpoint target given its role in …

    jhu Repository record for A Fc Domain-Conjugated Adenosine 2A Receptor Ligand for Immune Checkpoint Blockade (opens in a new tab)

  6. Using Genetically Heterogenous Mice To Identify Regulators Of Immune Checkpoint Blockade Response

    Immune Checkpoint Inhibitors (ICI) have dramatically improved patient outcomes in metastatic lung cancer, metastatic melanoma, subtypes of renal cancer and others. However, despite the clinical success, most patients still fail to have a durable response. Understanding what determines response and …

    wayne-thes Repository record for Using Genetically Heterogenous Mice To Identify Regulators Of Immune Checkpoint Blockade Response (opens in a new tab)

  7. Immune Checkpoint Blockade Induces Gut Microbiota Translocation That Augments Extraintestinal Anti-Tumor Immunity

    Gut microbiota are critical for effective immune checkpoint blockade therapy (ICT) for cancer. The mechanisms by which gut microbiota augment extraintestinal anti-cancer immune responses, however, are largely unknown. Here, we find that ICT induces the translocation of specific endogenous gut …

    utswmed Repository record for Immune Checkpoint Blockade Induces Gut Microbiota Translocation That Augments Extraintestinal Anti-Tumor Immunity (opens in a new tab)

  8. Enhancing immune checkpoint blockade and cancer immunotherapy via tissue targeting and biomaterial nanoparticles

    Immune checkpoint blockade (ICB) has emerged in recent years as one of the most promising new cancer therapies. However, a significant majority of patients receiving these therapies 1) do not respond, 2) experience adverse side effects, or 3) respond initially but relapse. Overcoming these …

    gatech Repository record for Enhancing immune checkpoint blockade and cancer immunotherapy via tissue targeting and biomaterial nanoparticles (opens in a new tab)

  9. Tumor Interferon Signaling Initiates And Sustains A Multigenic Resistance Program To Immune Checkpoint Blockade

    Therapeutic blockade of the CTLA4 and/or PD1 immune checkpoint pathways has resulted in significant anti-tumor responses in broad variety of cancer types, but resistance is common. Using mouse models of metastatic melanoma and breast cancer in combination with CRISPR/Cas9 to selectively delete …

    penn Repository record for Tumor Interferon Signaling Initiates And Sustains A Multigenic Resistance Program To Immune Checkpoint Blockade (opens in a new tab)

  10. Leveraging Macrophage Immune Checkpoint Blockade To Link Innate And Adaptive Immunity Against Solid Tumors

    Immunotherapies harness the power of the immune system, broadly, to identify, suppress, or otherwise control disease progression. Potent immune checkpoints, such as PD-1/PD-L1, CTLA4, and here, CD47-SIRPα restrain immunity in normal regulation to protect healthy ‘self’ cells, yet can become …

    penn Repository record for Leveraging Macrophage Immune Checkpoint Blockade To Link Innate And Adaptive Immunity Against Solid Tumors (opens in a new tab)

  11. Unraveling Host-Gut Microbiota Dialogue and Its Impact On Response to Immune Checkpoint Blockade

    … medicine that leverages the power of the human immune system to fight disease. In this way, it affords robust treatment choices for patients thought to have intractable disease. One specific type of immunotherapy shown to have a significant clinical benefit for cancer patients is monoclonal …

    uthsc Repository record for Unraveling Host-Gut Microbiota Dialogue and Its Impact On Response to Immune Checkpoint Blockade (opens in a new tab)

  12. Breast Cancer Stem Cell Targeting Nano-Chemotherapy and its Synergistic Effects with Immune Checkpoint Blockade

    … is further amplified by the overexpression of immune checkpoints on cancer cells, primarily CD47 and PD-L1, which enable evasion of macrophage and T cell-mediated immune surveillance. Therefore, innovative strategies targeting both bulk cancer cells and BCSCs, while simultaneously activating …

    auckland-ms Repository record for Breast Cancer Stem Cell Targeting Nano-Chemotherapy and its Synergistic Effects with Immune Checkpoint Blockade (opens in a new tab)

  13. Tumor Ripk1 Signaling Regulates Intrinsic And Extrinsic Mechanisms Of Resistance To Immune Checkpoint Blockade Therapy

    Immune checkpoint blockade therapy (ICB) can result in impressive clinical responses of multiple cancer types, however most patients fail to respond. Mechanisms of resistance include both tumor-intrinsic evasion of immune mediated killing and tumor-extrinsic features in the immune-microenvironment, …

    penn Repository record for Tumor Ripk1 Signaling Regulates Intrinsic And Extrinsic Mechanisms Of Resistance To Immune Checkpoint Blockade Therapy (opens in a new tab)

  14. Potentiation of The Immune Checkpoint Blockade Response By Metabolic Modulation Is Predictable Using Molecular Imaging

    … tumor microenvironment (TME) for antitumor immune cells, protecting the tumor from immune cell-mediated control and immunotherapy. Two of these environmental factors, acidosis and hypoxia, are commonly found in solid cancers. In my thesis, I posited that modulation of tumor acidosis and …

    uthsc Repository record for Potentiation of The Immune Checkpoint Blockade Response By Metabolic Modulation Is Predictable Using Molecular Imaging (opens in a new tab)

  15. Dissecting peripheral CD8+ T cell responses and immune interactions during immune checkpoint blockade for metastatic melanoma

    <p>Immune checkpoint blockade has provided a revolution in solid cancer treatment particularly in the metastatic setting. Although many patients demonstrate clinical responses upon receiving checkpoint therapy, a considerable number of individuals fail to benefit from treatment and continue to …

    oxford Repository record for Dissecting peripheral CD8+ T cell responses and immune interactions during immune checkpoint blockade for metastatic melanoma (opens in a new tab)

  16. Oncolytic herpes simplex virus immuno-virotherapy in combination with TIGIT immune checkpoint blockade to treat glioblastoma

    … perform in vitro screens for upregulation of immune checkpoint molecules in infected glioma cells, and evaluate the antitumor activity of the most promising combination immunovirotherapies. METHODS: The oncolytic activity of HSV-1 rQNestin34.5 was evaluated in CT-2A and GL261 syngeneic murine …

    bu Repository record for Oncolytic herpes simplex virus immuno-virotherapy in combination with TIGIT immune checkpoint blockade to treat glioblastoma (opens in a new tab)

  17. Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer

    <p><b>Background:</b> Immune checkpoint blockade (ICB) is arguably the greatest advance in medical oncology this century. Nonetheless, responses are highly variable. Mechanistic insights into this heterogeneity promises to improve patient stratification and identification of therapeutic targets. …

    oxford Repository record for Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer (opens in a new tab)

Page 1 of 13